Evaluation of pancreatic tissue penetration of Meronem [meropenem] in the prophylaxis of septic complications in severe pancreatitis
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections; Pancreatitis; Sepsis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 04 Sep 2017 Last checked against ClinicalTrials.gov record
- 11 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 30 Mar 2006 New trial record.